Neurocrine Biosciences Inc NBIX
998 filings, 9 in the last 30 days
SEC filing indexWhat the 8-Ks said
None of the officer, auditor, restatement, cyber, restructuring, listing, impairment or debt 8-Ks in the last 3 years
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 85 events
- Nov 10, 2026 Planned sale SANJAY KESWANI (Former Affiliate) gave notice of a planned sale of 53,614 shares worth about $9.0MForm 144, approximate sale date Nov 10, 2026
- Nov 2, 2026 Planned sale GEORGE MORROW (Director) gave notice of a planned sale of 14,700 shares worth about $2.1MForm 144, approximate sale date Nov 2, 2026, under a 10b5-1 plan adopted May 26, 2026
- Nov 2, 2026 Planned sale Sanjay Keswani (Chief Medical Officer (through Sep. 25, 2026)) adopted a 10b5-1 trading planreported in the 10-Q, up to 11,200 shares, runs to Jan 30, 2027
- Nov 2, 2026 Planned sale David Boyer (Chief Corporate Affairs Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 4,512 shares, runs to May 18, 2028
- Nov 2, 2026 Planned sale Gary Lyons (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 15,000 shares, runs to May 22, 2027
- Nov 2, 2026 Planned sale Richard Pops (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 15,000 shares, runs to May 21, 2027
- Nov 2, 2026 Planned sale Julie Cooke (Chief Human Resource Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 15,686 shares, runs to Mar 31, 2027
- Nov 2, 2026 Planned sale William Rastetter (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 18,000 shares, runs to May 22, 2027
- Nov 2, 2026 8-K Quarterly results8-K item 2.02
- Nov 2, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 30, 2026 Planned sale GEORGE MORROW (Director) gave notice of a planned sale of 300 shares worth about $44KForm 144, approximate sale date Oct 30, 2026, under a 10b5-1 plan adopted May 26, 2026
- Sep 28, 2026 8-K Director or officer change8-K item 5.02
- Sep 14, 2026 Planned sale DAVID WARREN BOYER (Officer) gave notice of a planned sale of 4,714 shares worth about $736KForm 144, approximate sale date Sep 14, 2026, under a 10b5-1 plan adopted Feb 23, 2026
- Sep 14, 2026 Planned sale MATTHEW C ABERNETHY (Officer) gave notice of a planned sale of 2,311 shares worth about $361KForm 144, approximate sale date Sep 14, 2026, under a 10b5-1 plan adopted May 22, 2026
- Sep 9, 2026 Planned sale ERIC BENEVICH (Officer) gave notice of a planned sale of 2,154 shares worth about $334KForm 144, approximate sale date Sep 9, 2026, under a 10b5-1 plan adopted Jun 10, 2026
- Jul 31, 2026 Planned sale Matthew Abernethy (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 77,176 shares, runs to May 22, 2027
- Jul 31, 2026 Planned sale George Morrow (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 15,000 shares, runs to May 22, 2027
- Jul 31, 2026 Planned sale Eric Benevich (Chief Commercial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 15,300 shares, runs to May 31, 2027
- Jul 31, 2026 8-K Current report (amended)8-K
- Jul 31, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 30, 2026 8-K Quarterly results8-K item 2.02
- Jul 10, 2026 Planned sale INGRID DELAET (Officer) gave notice of a planned sale of 4,367 shares worth about $788KForm 144, approximate sale date Jul 10, 2026, under a 10b5-1 plan adopted Feb 27, 2026
- Jul 9, 2026 Planned sale DARIN LIPPOLDT (Officer) gave notice of a planned sale of 10,000 shares worth about $1.8MForm 144, approximate sale date Jul 9, 2026, under a 10b5-1 plan adopted Jun 9, 2025
- Jul 7, 2026 Planned sale INGRID DELAET (Officer) gave notice of a planned sale of 14,571 shares worth about $2.5MForm 144, approximate sale date Jul 7, 2026, under a 10b5-1 plan adopted Feb 27, 2026
- Jun 29, 2026 Planned sale DARIN LIPPOLDT (Officer) gave notice of a planned sale of 9,800 shares worth about $1.7MForm 144, approximate sale date Jun 29, 2026, under a 10b5-1 plan adopted Jun 9, 2025
- Jun 26, 2026 Planned sale DARIN LIPPOLDT (Officer) gave notice of a planned sale of 200 shares worth about $33KForm 144, approximate sale date Jun 26, 2026, under a 10b5-1 plan adopted Jun 9, 2025
- Jun 5, 2026 Planned sale STEPHEN SHERWIN (Director) gave notice of a planned sale of 25,000 shares worth about $4.2MForm 144, approximate sale date Jun 5, 2026, under a 10b5-1 plan adopted Mar 6, 2026
- Jun 2, 2026 Planned sale JULIE COOKE (Officer) gave notice of a planned sale of 36,937 shares worth about $5.9MForm 144, approximate sale date Jun 2, 2026, under a 10b5-1 plan adopted Mar 3, 2026
- Jun 1, 2026 Planned sale JUDE ONYIA (Officer) gave notice of a planned sale of 11,000 shares worth about $1.7MForm 144, approximate sale date Jun 1, 2026, under a 10b5-1 plan adopted Feb 25, 2026
- May 29, 2026 Planned sale INGRID DELAET (Officer) gave notice of a planned sale of 2,261 shares worth about $354KForm 144, approximate sale date May 29, 2026, under a 10b5-1 plan adopted Feb 27, 2026
- May 28, 2026 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- May 27, 2026 Planned sale JUDE ONYIA (Officer) gave notice of a planned sale of 11,000 shares worth about $1.7MForm 144, approximate sale date May 27, 2026, under a 10b5-1 plan adopted Feb 25, 2026
- May 26, 2026 Planned sale DAVID WARREN BOYER (Officer) gave notice of a planned sale of 3,888 shares worth about $609KForm 144, approximate sale date May 26, 2026, under a 10b5-1 plan adopted Feb 23, 2026
- May 19, 2026 Planned sale KEVIN CHARLES GORMAN (Director) gave notice of a planned sale of 245,088 shares worth about $38.5MForm 144, approximate sale date May 19, 2026, under a 10b5-1 plan adopted Feb 17, 2026
- May 18, 2026 8-K Material agreement signed, Acquisition or sale of assets completed, New debt or obligation, Regulation FD disclosure8-K items 1.01, 2.01, 2.03, 7.01
- May 15, 2026 Planned sale RICHARD F POPS (Director) gave notice of a planned sale of 15,000 shares worth about $2.4MForm 144, approximate sale date May 15, 2026, under a 10b5-1 plan adopted Feb 13, 2026
- May 12, 2026 Planned sale Norwalk Leslie V (Director) gave notice of a planned sale of 6,310 shares worth about $1.0MForm 144, approximate sale date May 12, 2026, under a 10b5-1 plan adopted Sep 15, 2025
- May 5, 2026 Planned sale Darin Lippoldt (Chief Legal Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 1,250 shares
- May 5, 2026 Planned sale David Boyer (Chief Corporate Affairs Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 1,104 shares, runs to Feb 23, 2027
- May 5, 2026 Planned sale Eric Benevich (Chief Commercial Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 1,207 shares
- May 5, 2026 Planned sale Ingrid Delaet (Chief Regulatory Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 422 shares, runs to Feb 28, 2027
- May 5, 2026 Planned sale Jude Onyia (Chief Scientific Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 2,457 shares, runs to Feb 15, 2027
- May 5, 2026 Planned sale Julie Cooke (Chief Human Resources Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 916 shares, runs to Dec 31, 2026
- May 5, 2026 Planned sale Kevin Gorman (Director) ended a 10b5-1 trading planreported in the 10-Q, up to 2,707 shares, runs to Feb 6, 2027
- May 5, 2026 Planned sale Kyle Gano (Chief Executive Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 1,541 shares, runs to Feb 6, 2027
- May 5, 2026 Planned sale Matthew Abernethy (Chief Financial Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 1,283 shares
- May 5, 2026 Planned sale Richard Pops (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 30,000 shares, runs to Aug 15, 2026
- May 5, 2026 Planned sale Stephen Sherwin (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 25,000 shares, runs to Jun 4, 2027
- May 5, 2026 8-K Quarterly results8-K item 2.02
- May 5, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 6, 2026 8-K Material agreement signed8-K item 1.01
- Feb 11, 2026 8-K Quarterly results8-K item 2.02
- Feb 11, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Jan 16, 2026 Planned sale KYLE GANO (Officer) gave notice of a planned sale of 36,400 shares worth about $4.9MForm 144, approximate sale date Jan 16, 2026, under a 10b5-1 plan adopted May 20, 2025
- Dec 15, 2025 Planned sale Norwalk Leslie V (Director) gave notice of a planned sale of 11,250 shares worth about $1.7MForm 144, approximate sale date Dec 15, 2025, under a 10b5-1 plan adopted Sep 15, 2025
- Dec 8, 2025 Planned sale DARIN LIPPOLDT (Officer) gave notice of a planned sale of 4,376 shares worth about $681KForm 144, approximate sale date Dec 8, 2025, under a 10b5-1 plan adopted Jun 9, 2025
- Dec 3, 2025 Planned sale GARY A LYONS REVOCABLE LIVING U/A DTD 06/08/2012 (Director) gave notice of a planned sale of 15,000 shares worth about $2.3MForm 144, approximate sale date Dec 3, 2025, under a 10b5-1 plan adopted Sep 3, 2025
- Nov 28, 2025 Planned sale ERIC BENEVICH (Officer) gave notice of a planned sale of 5,970 shares worth about $905KForm 144, approximate sale date Nov 28, 2025, under a 10b5-1 plan adopted Aug 28, 2025
- Nov 25, 2025 Planned sale GEORGE MORROW (Director) gave notice of a planned sale of 15,000 shares worth about $2.1MForm 144, approximate sale date Nov 25, 2025, under a 10b5-1 plan adopted Aug 26, 2025
- Nov 24, 2025 8-K Director or officer change8-K item 5.02
- Oct 28, 2025 Planned sale William Rastetter (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 18,000 shares, runs to May 19, 2026
- Oct 28, 2025 Planned sale George Morrow (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 15,000 shares, runs to May 19, 2026
- Oct 28, 2025 Planned sale Eric Benevich (Chief Commercial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 12,830 shares, runs to Feb 4, 2026
- Oct 28, 2025 Planned sale Gary Lyons (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 15,000 shares, runs to May 19, 2026
- Oct 28, 2025 Planned sale Leslie Norwalk (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 15,000 shares, runs to Sep 12, 2026
- Oct 28, 2025 8-K Quarterly results8-K item 2.02
- Oct 28, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Jul 30, 2025 Planned sale Kyle Gano (Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 96,400 shares, runs to Feb 4, 2026
- Jul 30, 2025 Planned sale Matthew Abernethy (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 77,176 shares, runs to Feb 28, 2026
- Jul 30, 2025 Planned sale Darin Lippoldt (Chief Legal Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 122,989 shares, runs to Feb 28, 2027
- Jul 30, 2025 8-K Quarterly results8-K item 2.02
- Jul 30, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- May 30, 2025 8-K Director or officer change8-K item 5.02
- May 22, 2025 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- May 5, 2025 Planned sale Kevin Gorman, Ph.D. (Director) ended a 10b5-1 trading planreported in the 10-Q, up to 115,935 shares, runs to Feb 4, 2026
- May 5, 2025 8-K Quarterly results8-K item 2.02
- May 5, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Apr 4, 2025 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Feb 10, 2025 Planned sale Stephen A. Sherwin, M.D. (Director) adopted a 10b5-1 trading planreported in the 10-K, up to 13,831 shares, runs to May 7, 2025
- Feb 10, 2025 Planned sale Jude Onyia, Ph.D. (Chief Scientific Officer) ended a 10b5-1 trading planreported in the 10-K, up to 89,090 shares, runs to Dec 31, 2025
- Feb 10, 2025 Planned sale David W. Boyer (Chief Corporate Affairs Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 18,571 shares, runs to Feb 15, 2025
- Feb 10, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Feb 6, 2025 8-K Quarterly results8-K item 2.02
- Jan 27, 2025 8-K Material agreement signed, Regulation FD disclosure8-K items 1.01, 7.01
- Dec 20, 2024 8-K Other events8-K item 8.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 10, 2026 | 144 | Notice of planned insider sale |
| Nov 5, 2026 | 4 | Insider trade |
| Nov 3, 2026 | 4 | Insider trade |
| Nov 3, 2026 | 4 | Insider trade |
| Nov 2, 2026 | 144 | Notice of planned insider sale |
| Nov 2, 2026 | 10-Q | Quarterly report |
| Nov 2, 2026 | 8-K | Quarterly results |
| Oct 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Oct 30, 2026 | 144 | Notice of planned insider sale |
| Oct 15, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 7, 2026 | 3 | New insider |
| Sep 28, 2026 | 8-K | Director or officer change |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 14, 2026 | 144 | Notice of planned insider sale |
| Sep 14, 2026 | 144 | Notice of planned insider sale |
| Sep 10, 2026 | 4 | Insider trade |
| Sep 9, 2026 | 144 | Notice of planned insider sale |
| Sep 3, 2026 | 4 | Insider trade |
| Aug 5, 2026 | 4 | Insider trade |
| Jul 31, 2026 | 8-K/A | Current report (amended) |
| Jul 31, 2026 | S-8 | Shares registered for employee plans |
| Jul 31, 2026 | 10-Q | Quarterly report |
| Jul 30, 2026 | 4 | Insider trade |
| Jul 30, 2026 | 8-K | Quarterly results |
| Jul 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 13, 2026 | 4 | Insider trade |
| Jul 13, 2026 | 4 | Insider trade |
| Jul 10, 2026 | 144 | Notice of planned insider sale |
| Jul 9, 2026 | 4 | Insider trade |
| Jul 9, 2026 | 144 | Notice of planned insider sale |
| Jul 7, 2026 | 144 | Notice of planned insider sale |
| Jun 30, 2026 | 4 | Insider trade |
| Jun 29, 2026 | 144 | Notice of planned insider sale |
| Jun 26, 2026 | 144 | Notice of planned insider sale |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 144 | Notice of planned insider sale |
| Jun 4, 2026 | 4 | Insider trade |
| Jun 4, 2026 | 4 | Insider trade |
| Jun 2, 2026 | 4 | Insider trade |
| Jun 2, 2026 | 144 | Notice of planned insider sale |
| Jun 2, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 144 | Notice of planned insider sale |
| May 29, 2026 | 144 | Notice of planned insider sale |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 28, 2026 | 4 | Insider trade |
| May 28, 2026 | 8-K | Director or officer change, Shareholder vote results |
| May 27, 2026 | 144 | Notice of planned insider sale |
| May 26, 2026 | 144 | Notice of planned insider sale |
| May 21, 2026 | 4 | Insider trade |
| May 21, 2026 | 4 | Insider trade |
| May 21, 2026 | 4 | Insider trade |
| May 21, 2026 | 4 | Insider trade |
| May 21, 2026 | 4 | Insider trade |
| May 21, 2026 | 4 | Insider trade |
| May 21, 2026 | 4 | Insider trade |
| May 21, 2026 | 4 | Insider trade |
| May 21, 2026 | 4 | Insider trade |
| May 21, 2026 | 4 | Insider trade |
| May 19, 2026 | 144 | Notice of planned insider sale |
| May 18, 2026 | 8-K | Material agreement signed, Acquisition or sale of assets completed, New debt or obligation, Regulation FD disclosure |
| May 18, 2026 | SC TO-T/A | |
| May 18, 2026 | 4 | Insider trade |
| May 15, 2026 | 144 | Notice of planned insider sale |
| May 14, 2026 | 4 | Insider trade |
| May 12, 2026 | 144 | Notice of planned insider sale |
| May 5, 2026 | 10-Q | Quarterly report |
| May 5, 2026 | 8-K | Quarterly results |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 29, 2026 | SC TO-T/A | |
| Apr 28, 2026 | SC TO-T/A | |
| Apr 20, 2026 | SC TO-T | |
| Apr 15, 2026 | ARS | Annual report to shareholders |
| Apr 15, 2026 | DEFA14A | Extra proxy material |
| Apr 15, 2026 | DEF 14A | Proxy statement |
| Apr 7, 2026 | SC TO-C | |
| Apr 6, 2026 | SC TO-C | |
| Apr 6, 2026 | SC TO-C | |
| Apr 6, 2026 | 8-K | Material agreement signed |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/NBIX/export.csv") into a cell.